Concepedia

Charlotte Kopitz

CK

25

Publications

2.6K

Citations

20

H-Index

2001

Active since

Affiliations

Bayer (Germany)(Current)

Klinikum rechts der Isar

Technical University of Munich

Broad Institute

Radboud Institute for Molecular Life Sciences

Charlotte Kopitz is an author at Bayer (Germany) specializing in medicine, tumor microenvironment, and tumor biology.

Top concepts

Publications per year

2001–2022

25

Publications

25

Mitochondrial complex I inhibition triggers a mitophagy-dependent ROS increase leading to necroptosis and ferroptosis in melanoma cells

Farhan Basit, Lisanne MPE van Oppen, Laura Schöckel et al. · Cell Death and Disease · 2017 · 551 citations · Full text

Evidence for an alternative fatty acid desaturation pathway increasing cancer plasticity

Kim Vriens, Stefan Christen, Sweta Parik et al. · Nature · 2019 · 468 citations · Full text

, , +8

Anetumab Ravtansine: A Novel Mesothelin-Targeting Antibody–Drug Conjugate Cures Tumors with Heterogeneous Target Expression Favored by Bystander Effect

Sven Golfier, Charlotte Kopitz, Antje Kahnert et al. · Molecular Cancer Therapeutics · 2014 · 245 citations

Targeting mitochondrial complex I using BAY 87-2243 reduces melanoma tumor growth

Laura Schöckel, Andrea Glasauer, Farhan Basit et al. · Cancer & Metabolism · 2015 · 155 citations · Full text

Tissue Inhibitor of Metalloproteinases-1 Promotes Liver Metastasis by Induction of Hepatocyte Growth Factor Signaling

Charlotte Kopitz, Michael Gerg, Obul Reddy Bandapalli et al. · Cancer Research · 2007 · 141 citations

Rows per page

1–5 of 25